AAAAAA

   
Results: 1-9 |
Results: 9
Quality of life in lung cancer patients
Authors: Gridelli, C Perrone, F Nelli, F Ramponi, S De Marinis, F
Citation: C. Gridelli et al., Quality of life in lung cancer patients, ANN ONCOL, 12, 2001, pp. S21-S25
Toxicity in small cell lung cancer (SCLC) patients submitted to twice-daily or once-daily thoracic radiotherapy (TRT) and concomitant chemotherapy (CT) long-term results
Authors: Maranzano, E Piro, F Meacci, L Bracarda, S De Angelis, V Crino, L De Marinis, F Minciarelli, M Tonato, M Latini, P
Citation: E. Maranzano et al., Toxicity in small cell lung cancer (SCLC) patients submitted to twice-daily or once-daily thoracic radiotherapy (TRT) and concomitant chemotherapy (CT) long-term results, TUMORI, 87(4), 2001, pp. S122-S123
A three-week schedule of gemcitabine-cisplatin in advanced non-small-cell lung cancer with two different cisplatin dose levels: A phase II randomizedtrial
Authors: Rinaldi, M Crino, L Scagliotti, GV Mosconi, AM De Marinis, F Gridelli, C Selvaggi, G Della Giulia, M Darwish, S Porrozzi, S Novello, S Cipri, A Bartolucci, R Calandri, C Tonato, M
Citation: M. Rinaldi et al., A three-week schedule of gemcitabine-cisplatin in advanced non-small-cell lung cancer with two different cisplatin dose levels: A phase II randomizedtrial, ANN ONCOL, 11(10), 2000, pp. 1295-1300
Awareness of disease among Italian cancer patients: Is there a need for further improvement in patient information?
Authors: Ruggeri, B Ballatori, E Casali, P Tamburini, M Licitra, L Mencaglia, E Roila, F Cortesi, E Massidda, B Costantini, M De Angelis, V Ciccarese, G Mattei, A Valori, VM Lelli, G Nanni, L Romano, MP Di Maggio, G Morritti, MG Di Micco, C Palladino, MA Porrozzi, S De Angelis, V Ciccarese, G Milella, G Bruno, ML Basurto, C Locatelli, MC Valsecchi, R Zamparelli, G Pessi, A Molaro, O Luporini, G Giovanni, S Bertetto, O Donadio, M Fanchini, L Mistrangelo, M Bumma, C Parello, G Malacarne, P Donati, D Scapoli, D Ferrari, A Olmi, P Galardi, A Panichi, M Ruggiero, C Zironi, S Banzi, C Piccinini, L Campora, E Venturino, A Vincenti, M Gasco, M Marchioro, G Barbato, F Azzarello, G Vinante, O Sabbioni, R Nortilli, R Griso, C Cetto, L Aste, MG Pasqualucci, S Chierchi, MC Floris, C Barbieri, E Frezza, G Bunkeila, F Bonci, F Sarobba, MG Farris, A Sanna, G Ionta, MT Murru, R Mascia, MG Lopez, M Amodio, A Paoletti, G Timio, L Romano, M Amichetti, M Barni, S Ardizzoia, A Mandala, M Maxia, G Dessi, M Acito, L Giustini, L Casarini, MB Smerieri, F Riva, N Maltoni, M Antimi, M Bellini, V Boz, G Brema, F De Candis, D Polico, C Mandoliti, G Amendola, P Iacono, C Imperato, A Gelmi, S Giovanni, S Maluta, S Selvestrel, C Cognetti, F Barduagni, M Fusco, V Rossi, M Bracci, R Antognoli, S Mascia, V Farci, D Vitale, V Musi, M Grasso, F Nicodemo, M Cirillo, M Botta, M De Giovanni, D Giuliodori, L Silva, RR Martignetti, A Deplacido, S Domini, P Gareri, R Porcile, G Dalla Mola, A Ambrosini, G Casi, C Del Favero, A Pignata, S Ricchi, P Folco, U Castellana, MA Salvi, G Lionello, R Gaion, F Ronco, M Troccoli, G Ranuzzi, M Marchetti, P Montinari, F Fioretto, L Palmeri, S Sassi, M Carreca, I Cinieri, S Graiff, C Cariello, S Mantovani, G Lazzaro, B Spada, S Rosati, G De Marinis, F Gravina, A La Ciura, P Ognibeni, M Iannone, T Pusceddu, G Buffoli, A Marcellini, M
Citation: B. Ruggeri et al., Awareness of disease among Italian cancer patients: Is there a need for further improvement in patient information?, ANN ONCOL, 10(9), 1999, pp. 1095-1100
Gemcitabine as second-line treatment for advanced non-small-cell lung cancer: A phase II trial
Authors: Crino, L Mosconi, AM Scagliotti, G Selvaggi, G Novello, S Rinaldi, M Della Giulia, M Gridelli, C Rossi, A Calandri, C De Marinis, F Noseda, M Tonato, M
Citation: L. Crino et al., Gemcitabine as second-line treatment for advanced non-small-cell lung cancer: A phase II trial, J CL ONCOL, 17(7), 1999, pp. 2081-2085
Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian lung cancer project
Authors: Crino, L Scagliotti, GV Ricci, S De Marinis, F Rinaldi, M Gridelli, C Ceribelli, A Bianco, R Marangolo, M Di Costanzo, F Sassi, M Barni, S Ravaioli, A Adamo, V Portalone, L Cruciani, G Masotti, A Ferrara, G Gozzelino, F Tonato, M
Citation: L. Crino et al., Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian lung cancer project, J CL ONCOL, 17(11), 1999, pp. 3522-3530
The role of vindesine and lonidamine in the treatment of elderly patients with advanced non-small cell lung cancer: A phase III randomized FONICAP trial
Authors: De Marinis, F Rinaldi, M Ardizzoni, A Bruzzi, P Pennucci, MC Portalone, L D'Aprile, M Ripanti, P Romano, F Belli, M Altavilla, G Migliorino, MR Rosso, R Salvati, F
Citation: F. De Marinis et al., The role of vindesine and lonidamine in the treatment of elderly patients with advanced non-small cell lung cancer: A phase III randomized FONICAP trial, TUMORI, 85(3), 1999, pp. 177-182
Patient compliance with quality of life questionnaires
Authors: Roila, F Ballatori, E Mattei, A Cortesi, E Tamburini, M Casali, P Licitra, L Mencaglia, E Costantini, M Massidda, B De Angelis, V Ciccarese, G Valori, VM Lelli, G Nanni, L Romano, MP Di Maggio, G Morritti, MG Di Micco, C Palladino, MA Porrozzi, S Milella, G Locatelli, MC Valsecchi, V Zamparelli, G Pessi, A Molaro, O Luporini, G Bertetto, O Donadio, M Fanchini, L Mistrangelo, M Bumma, C Parello, G Malacarne, P Donati, D Scapoli, D Ferrari, A Olmi, P Galardi, A Panichi, M Ruggiero, C Zironi, S Banzi, C Piccinini, L Campora, E Venturino, A Vincenti, M Gasco, M Marchioro, G Barbato, F Azzarello, G Vinante, O Sabbioni, R Nortilli, R Griso, C Cetto, L Aste, MG Pasqualucci, S Chierchi, MC Floris, C Barbieri, E Frezza, G Bunkeila, F Bonci, F Sarobba, MG Farris, A Sanna, G Ionta, MT Murru, R Mascia, MG Lopez, M Amodio, A Paoletti, G Tomio, L Romano, M Amichetti, M Barni, S Ardizzoia, A Mandala, M Maxia, G Dessi, M Acito, L Giustini, L Casarini, MB Smerieri, F Riva, N Maltoni, M Antimi, M Bellini, V Boz, G Brema, F Mencaglia, E De Candis, D Polico, C Mandoliti, G Amendola, P Iacono, C Imperato, A Gelmi, S Maluta, S Selvestrel, C Giovanni, S Cognetti, F Barduagni, M Fusco, V Pozzi, G Bracci, R Antognoli, S Mascia, V Farci, D Vitale, V Musi, M Grasso, F Nicodemo, M Cirillo, M Botta, M De Giovanni, D Giuliodori, L Silva, RR Martignetti, A Domini, P Gareri, R Porcile, G Dalla Mola, A Ambrosini, G Casi, C Del Favero, A Pignata, S Ricchi, P Folco, U Castellana, MA Salvi, G Lionello, R Gaion, F Ronco, M Troccoli, G Ranuzzi, M Marchetti, P Montinari, F Fioretto, L Palmeri, S Sassi, M Carreca, I Cinieri, S Graiff, C Cariello, S Mantovani, G Lazzaro, B Spada, S Rosati, G De Marinis, F Gravina, A La Ciura, P Ognibeni, M Iannone, T Pusceddu, G Buffoli, A Menichetti, ET
Citation: F. Roila et al., Patient compliance with quality of life questionnaires, TUMORI, 85(2), 1999, pp. 92-95
Phase II study of the activity and tolerability of a combined regimen of high-dose epirubicin and cisplatin in stage IIIb and IV non-small cell lung cancer
Authors: Clerici, M De Marinis, F Piazza, E Frontini, L Tucci, E Barni, S Bretti, S Luporini, G Intini, C
Citation: M. Clerici et al., Phase II study of the activity and tolerability of a combined regimen of high-dose epirubicin and cisplatin in stage IIIb and IV non-small cell lung cancer, TUMORI, 84(6), 1998, pp. 669-672
Risultati: 1-9 |